Cargando…
Safety and efficacy of carmustine (BCNU) wafers for metastatic brain tumors
BACKGROUND: Carmustine (BCNU) wafers (Gliadel) prolongs local disease control and progression-free survival (PFS) in patients with malignant gliomas. However, in metastatic brain tumors, there is a paucity of evidence in support of its safety and efficacy. The goal of this study was to assess the sa...
Autores principales: | Ene, Chibawanye I., Nerva, John D., Morton, Ryan P., Barkley, Ariana S., Barber, Jason K., Ko, Andrew L., Silbergeld, Daniel L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4866053/ https://www.ncbi.nlm.nih.gov/pubmed/27217968 http://dx.doi.org/10.4103/2152-7806.181987 |
Ejemplares similares
-
Treatment of Gliomas: How did we get here?
por: Chowdhary, Michelle M., et al.
Publicado: (2015) -
Personalized Medicine for Gliomas
por: Ene, Chibawanye I., et al.
Publicado: (2015) -
Introduction – Supplement on brain metastases
por: Silbergeld, Daniel
Publicado: (2013) -
Controversies in the management of brain metastases
por: Levitt, Michael R., et al.
Publicado: (2013) -
Is Interstitial Chemotherapy with Carmustine (BCNU) Wafers Effective against Local Recurrence of Glioblastoma? A Pharmacokinetic Study by Measurement of BCNU in the Tumor Resection Cavity
por: Ohnishi, Takanori, et al.
Publicado: (2022)